Edit |   |
---|---|
Antigenic Specificity | APP, Human (Donanemab biosimilar) |
Clone | Donanemab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human APP Recombinant Antibody (Donanemab). Donanemab (USAN, development code LY3002813) is a biological drug in trial to treat early symptoms of Alzheimer's disease. There is no cure or treatment for Alzheimer's disease. Donanemab has shown positive results in Eli Lilly and Co.'s first two trials. |
Immunogen | n/a |
Other Names | Anti-APP Recombinant Antibody, Research Grade Donanemab, Anti-Human APP Recombinant Antibody(Donanemab), LY3002813, Antibody Drug Analogues, Monoclonal Antibody, YR1541, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1931944-80-7 |
Catalog # | YR1541 |
Price | please inquire |
Order / More Info | APP, Human (Donanemab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |